Clinical Trial Update: Risankizumab in Children With Crohn's Disease (RisaKids) [NA]

View source ↗

Summary

A pediatric trial called RisaKids is evaluating risankizumab (Skyrizi) for Crohn's disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• SKYRIZI (risankizumab-rzaa)

Snippet

Sponsor: Shaare Zedek Medical Center | Conditions: Crohn Disease | NA | Status: RECRUITING